Hepatitis B virus polymerase suppresses NF-κB signaling by inhibiting the activity of IKKs via interaction with Hsp90β

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Liu, Dan ^a   Wu, An'dong ^a   Cui, Lei ^a   Hao, Ruidong ^a   Wang, Yuan ^a   He, Jing ^a   Guo, Deyin ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CELL CYCLE PROTEIN 37; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; RNA POLYMERASE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR RECEPTOR 1; HSP90AB1 PROTEIN, HUMAN; P PROTEIN, HEPATITIS B VIRUS; POL PROTEIN; PROTEIN BINDING;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DISRUPTION; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOPRECIPITATION; INNATE IMMUNITY; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPERNATANT; WESTERN BLOTTING; CELL LINE; CELL NUCLEUS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; PROTEIN DEGRADATION; PROTEIN TRANSPORT;

CELL LINE; CELL NUCLEUS; GENE EXPRESSION; GENE PRODUCTS, POL; HEPATITIS B VIRUS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; I-KAPPA B KINASE; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEOLYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84897568235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091658     Document Type: Article

References (43)

1. Dienstag JL (2008) Hepatitis B virus infection. N Engl J Med 359: 1486-1500.
2. Summers J, Mason WS (1982) Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29: 403-415. (Pubitemid 12024833)
3. Bartenschlager R, Schaller H (1992) Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. Embo J 11: 3413-3420.
4. Pollack JR, Ganem D (1994) Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis. J Virol 68: 5579-5587. (Pubitemid 24258570)
5. Gyoo Park S, Kyung Rho J, Jung G (2002) Hsp90 makes the human HBV Pol competent for in vitro priming rather than maintaining the human HBV Pol/pregenomic RNA complex. Arch Biochem Biophys 401: 99-107.
6. Cho G, Suh SW, Jung G (2000) HBV polymerase interacts independently with N-terminal and C-terminal fragments of Hsp90beta. Biochem Biophys Res Commun 274: 203-211. (Pubitemid 30496780)
7. Cho G, Park SG, Jung G (2000) Localization of HSP90 binding sites in the human hepatitis B virus polymerase. Biochem Biophys Res Commun 269: 191-196. (Pubitemid 30440275)
8. Neckers L, Ivy SP (2003) Heat shock protein 90. Curr Opin Oncol 15: 419-424. (Pubitemid 38147036)
9. Pratt WB, Toft DO (2003) Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 228: 111-133. (Pubitemid 36187918)
10. Chen G, Cao P, Goeddel DV (2002) TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 9: 401-410. (Pubitemid 34195564)
11. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, et al. (2004) A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 6: 97-105. (Pubitemid 38425708)
12. Lewis J, Devin A, Miller A, Lin Y, Rodriguez Y, et al. (2000) Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factorkappaB activation. J Biol Chem 275: 10519-10526. (Pubitemid 30202115)
13. Citri A, Harari D, Shohat G, Ramakrishnan P, Gan J, et al. (2006) Hsp90 recognizes a common surface on client kinases. J Biol Chem 281: 14361-14369. (Pubitemid 43848365)
14. Field N, Low W, Daniels M, Howell S, Daviet L, et al. (2003) KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci 116: 3721-3728. (Pubitemid 37185301)
15. Hinz M, Broemer M, Arslan SC, Otto A, Mueller EC, et al. (2007) Signal responsiveness of IkappaB kinases is determined by Cdc37-assisted transient interaction with Hsp90. J Biol Chem 282: 32311-32319. (Pubitemid 350106474)
16. Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208.
17. Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses (without pdf). Annu Rev Immunol 16: 225-260. (Pubitemid 28183365)
18. Pomerantz JL, Baltimore D (2002) Two pathways to NF-kappaB. Mol Cell 10: 693-695.
19. Rothwarf DM, Zandi E, Natoli G, Karin M (1998) IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395: 297-300. (Pubitemid 28447557)
20. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M (1997) A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388: 548-554. (Pubitemid 27339997)
21. Delhase M, Hayakawa M, Chen Y, Karin M (1999) Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284: 309-313. (Pubitemid 129523447)
22. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
23. Claudio E, Brown K, Park S, Wang H, Siebenlist U (2002) BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 3: 958-965. (Pubitemid 35154010)
24. Coope HJ, Atkinson PG, Huhse B, Belich M, Janzen J, et al. (2002) CD40 regulates the processing of NF-kappaB2 p100 to p52. Embo J 21: 5375-5385. (Pubitemid 35231017)
25. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, et al. (2002) The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17: 525-535. (Pubitemid 35223540)
26. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, et al. (2001) Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293: 1495-1499. (Pubitemid 32801552)
27. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G (2006) Inflammation and cancer: how hot is the link? Biochem Pharmacol 72: 1605-1621. (Pubitemid 44666739)
28. Nam NH (2006) Naturally occurring NF-kappaB inhibitors (without pdf). Mini Rev Med Chem 6: 945-951.
29. Wang H, Ryu WS (2010) Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog 6: e1000986.
30. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, et al. (2004) Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126: 1750-1758. (Pubitemid 38736340)
31. Lucito R, Schneider RJ (1992) Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol 66: 983-991.
32. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U (1995) Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488.
33. Chen ZJ, Parent L, Maniatis T (1996) Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 84: 853-862. (Pubitemid 26106855)
34. Harling-McNabb L, Deliyannis G, Jackson DC, Gerondakis S, Grigoriadis G, et al. (1999) Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response. Int Immunol 11: 1431-1439. (Pubitemid 29425734)
35. Tait SW, Reid EB, Greaves DR, Wileman TE, Powell PP (2000) Mechanism of inactivation of NF-kappa B by a viral homologue of I kappa b alpha. Signal-induced release of i kappa b alpha results in binding of the viral homologue to NF-kappa B. J Biol Chem 275: 34656-34664.
36. Rodriguez CI, Nogal ML, Carrascosa AL, Salas ML, Fresno M, et al. (2002) African swine fever virus IAP-like protein induces the activation of nuclear factor kappa B. J Virol 76: 3936-3942. (Pubitemid 34250558)
37. Su F, Schneider RJ (1996) Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol 70: 4558-4566. (Pubitemid 26191145)
38. Hildt E, Saher G, Bruss V, Hofschneider PH (1996) The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 225: 235-239. (Pubitemid 26390072)
39. Wu M, Xu Y, Lin S, Zhang X, Xiang L, et al. (2007) Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. J Gen Virol 88: 3260-3269. (Pubitemid 350201835)
40. Hosel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, et al. (2009) Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50: 1773-1782.
41. Lara-Pezzi E, Majano PL, Gomez-Gonzalo M, Garcia-Monzon C, Moreno-Otero R, et al. (1998) The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Hepatology 28: 1013-1021. (Pubitemid 28450262)
42. Lee Y, Park US, Choi I, Yoon SK, Park YM, et al. (1998) Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Clin Cancer Res 4: 1711-1717. (Pubitemid 28304733)
43. Mahe Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, et al. (1991) Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem 266: 13759-13763. (Pubitemid 21907416)